CJC-1295 + Ipamorelin
Research blend combining CJC-1295 (No DAC) and Ipamorelin for synergistic studies.
Third-Party Tested by Janoshik Analytical
✓ In stock - Ships same day
Third-Party Tested by Janoshik Analytical
Description
CJC-1295 + Ipamorelin Blend combines a growth hormone-releasing hormone (GHRH) analog with a selective growth hormone secretagogue (GHS) for synergistic GH axis stimulation. CJC-1295 (without DAC) extends GHRH signaling while Ipamorelin selectively activates the ghrelin receptor (GHS-R1a) without affecting cortisol or prolactin.
Blend Composition:
- CJC-1295 (No DAC): GHRH analog (Modified GRF 1-29)
- Ipamorelin: Selective GHS-R1a agonist pentapeptide
Research Applications:
- Synergistic GH pulse amplitude and frequency studies
- IGF-1 axis modulation without cortisol elevation
- Body composition and lean mass research
- Sleep architecture and GH secretion pattern analysis
- Age-related GH decline countermeasure studies
Quality Standards:
- Each component: ≥99% purity verified by HPLC
- Third-party tested with COA included
FOR RESEARCH USE ONLY. Not for human consumption.
Technical Specifications
- Molecular Formula
- C152H252N44O42 + C38H49N9O5
- Molecular Weight
- 3367.97 + 711.85 g/mol
Frequently Researched Together
Commonly studied alongside in laboratory settings
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption.